Anti-obesity therapies

被引:79
作者
Melnikova, I
Wages, D
机构
[1] MEDACorp, Boston, MA 02110 USA
[2] Ariad Pharmaceut, Cambridge, MA 02139 USA
关键词
D O I
10.1038/nrd2037
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:369 / 370
页数:2
相关论文
共 3 条
[1]   Obesity: America's epidemic [J].
Daniels, J .
AMERICAN JOURNAL OF NURSING, 2006, 106 (01) :40-49
[2]   Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients - RIO-North America: A randomized controlled trial [J].
Pi-Sunyer, F ;
Aronne, LJ ;
Heshmati, HM ;
Devin, J ;
Rosenstock, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (07) :761-775
[3]   Pharmacology for obesity - Promise and uncertainty. [J].
Yanovski, SZ .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) :2187-2189